A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder - PubMed (original) (raw)
Clinical Trial
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder
D F Connor et al. Clin Pediatr (Phila). 2000 Jan.
Abstract
A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed. Study design was a 3-month, randomized, blinded, group comparison with eight subjects per group. No placebo comparison was used. All three treatment groups showed significant improvements in attention deficits, impulsivity, oppositional, and conduct disordered symptoms as assessed by parent and teacher rating scales and laboratory measures. Significant differences among treatment groups were found only on a few measures. Only the clonidine monotherapy group showed significantly decreased fine motor speed. These results suggest the safety and efficacy of clonidine alone or in combination with MPH for the treatment of ADHD and aggressive oppositional and conduct disorders.
Similar articles
- Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
Sinzig J, Döpfner M, Lehmkuhl G; German Methylphenidate Study Group; Uebel H, Schmeck K, Poustka F, Gerber WD, Günter M, Knölker U, Gehrke M, Hässler F, Resch F, Brünger M, Ose C, Fischer R. Sinzig J, et al. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):421-32. doi: 10.1089/cap.2007.0011. J Child Adolesc Psychopharmacol. 2007. PMID: 17822338 Clinical Trial. - Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study.
Kronenberger WG, Giauque AL, Lafata DE, Bohnstedt BN, Maxey LE, Dunn DW. Kronenberger WG, et al. J Child Adolesc Psychopharmacol. 2007 Jun;17(3):334-47. doi: 10.1089/cap.2006.0012. J Child Adolesc Psychopharmacol. 2007. PMID: 17630867 Clinical Trial. - Treatment of ADHD in children with tics: a randomized controlled trial.
Tourette's Syndrome Study Group. Tourette's Syndrome Study Group. Neurology. 2002 Feb 26;58(4):527-36. doi: 10.1212/wnl.58.4.527. Neurology. 2002. PMID: 11865128 Clinical Trial. - The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
Pringsheim T, Hirsch L, Gardner D, Gorman DA. Pringsheim T, et al. Can J Psychiatry. 2015 Feb;60(2):42-51. doi: 10.1177/070674371506000202. Can J Psychiatry. 2015. PMID: 25886655 Free PMC article. Review. - Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
Childress AC, Sallee FR. Childress AC, et al. Drugs Today (Barc). 2012 Mar;48(3):207-17. doi: 10.1358/dot.2012.48.3.1750904. Drugs Today (Barc). 2012. PMID: 22462040 Review.
Cited by
- Contemporary assessment and pharmacotherapy of Tourette syndrome.
Scahill L, Erenberg G, Berlin CM Jr, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J; Tourette Syndrome Association Medical Advisory Board: Practice Committee. Scahill L, et al. NeuroRx. 2006 Apr;3(2):192-206. doi: 10.1016/j.nurx.2006.01.009. NeuroRx. 2006. PMID: 16554257 Free PMC article. Review. - Managing attention deficit/hyperactivity disorder: unmet needs and future directions.
Steer CR. Steer CR. Arch Dis Child. 2005 Feb;90 Suppl 1(Suppl 1):i19-25. doi: 10.1136/adc.2004.059352. Arch Dis Child. 2005. PMID: 15665152 Free PMC article. Review. - Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.
Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Biederman J, et al. Pediatrics. 2009 Jul;124(1):71-8. doi: 10.1542/peds.2008-3347. Pediatrics. 2009. PMID: 19564285 Free PMC article. - ADHD in children and adolescents.
Keen D, Hadijikoumi I. Keen D, et al. BMJ Clin Evid. 2008 Oct 2;2008:0312. BMJ Clin Evid. 2008. PMID: 19445793 Free PMC article. Review. - Pharmacological aspects of the treatment of conduct disorder in children and adolescents.
Tcheremissine OV, Lieving LM. Tcheremissine OV, et al. CNS Drugs. 2006;20(7):549-65. doi: 10.2165/00023210-200620070-00002. CNS Drugs. 2006. PMID: 16800715 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical